Sources and our math, step by step:
About SN111 Claims
Sources and our math, step by step: $2.87T global R&D in 2024 (WIPO) bit.ly/4zdnkyC × 41% health and public R&D = $1.2T: business does 74% of R&D (OECD), health is 19.9% of corporate R&D (EU Scoreboard), plus all public research bit.ly/4e1tidB × 56% labour share of pharma R&D cost (NSF) bit.ly/3W9ovk8 × 20% of researcher time spent searching for and reading papers, about 9 hours a week (Elsevier & Sense about Science, 3,000+ researchers) = $130B bit.ly/4Bs93zG × 25%, our assumption = $33B. We round down to $30B. Caveats: This is the value of researcher time, not a revenue forecast. The 20% applies to all R&D labour, technicians included, so $130B is the upper end. And for scale, 25% is about half the time spent searching, with none of the reading.
Linkbit.lybit.ly/4zdnkyCSN111 Claims at a glance
SN111, Claims (α token Ё), is one of the independent markets on the Bittensor network, each with its own α token and its own price. Its α currently trades at 0.003962 τ (≈ $1.00), against 5,398 τ of pool liquidity. On-chain, the best-delegated validator on it yields about 34.95% APR (simple) and 41.83% APY (compounded), emissions add 0.000256 τ to the pool each block, epochs run every 360 blocks. It was registered at block #5,615,562.
Taosis newsletters
Taosis News: the week’s articles from the subnet teams, the press and community newsletters, every Friday. Taosis Weekly: the week’s movers, best yields and chain events, with dollar values, every Monday. Past issues
More from SN111 Claims
Taosis indexes announcements, articles, posts and releases about Bittensor subnets from their own channels and keeps a record of each. The text above is the source’s; the figures are read from the chain by Taosis.